DV
Dividend Vision

APLS — Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals Inc (APLS)

Total return is -76.0% over the past 8.8 years, 320.3 points behind SPY at 244.3%. Its deepest 1-year drawdown was 92.6%.

APLS is an equity stock that trades as an individual security rather than a diversified fund structure. As a single-company stock in the pharmaceutical sector, it does not have a defined dividend distribution rate or expense ratio typical of ETFs. This security appeals primarily to investors seeking direct exposure to a specific pharmaceutical company's performance rather than those pursuing passive dividend income strategies.

APLS key facts

Asset type
Stock
Asset class
Equity
Inception date
11/09/2017
Last close
$3.37
Market cap
$5,252,712,960
Average volume
0.0
Beta
-0.246
Payout ratio
0.0
P/E ratio
38.3458
Forward P/E
46.2963
EPS
$1.07